Literature DB >> 6930515

Prognostic factors for survival in patients with inoperable lung cancer.

K E Stanley.   

Abstract

Seventy-seven prognostic factors were considered in an evaluation of more than 5,000 patients with inoperable bronchogenic carcinoma of the lung; these patients were entered on the Veterans Administration Lung Group protocols 9-15 (1968-78). Fifty prognostic factors for survival were identified, and their relative contributions to patient survival were considered. The three most important prognostic factors affecting survival were the Karnofsky initial performance status score, extent of disease, and weight loss in the previous 6 months. These factors denoted three general prognostic components: current physical status, current disease status, and prior physical status. Initial performance status was the dominant prognostic factor. Characterization of patient's function status with the use of the Karnofsky scale was preferred to a summarized scale or a dichotomization into ambulatory versus nonambulatory. The current practice of dichotomizing factors resulted in the loss of much prognostic information. Other factors, such as tumor size, histologic type, and institution, appeared to be important when considered alone. However, their contribution was relatively minor after a correction was made for the effects of initial performance status, extent of disease, and prior weight loss. Depending on these three prognostic factors alone, median survival varied between 6 weeks and over a year. Reporting of results without the consideration of such prognostic factors severly hampers any comparisons that may be made between investigations.

Entities:  

Mesh:

Year:  1980        PMID: 6930515

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  92 in total

1.  Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan).

Authors:  M Sakurai; T Shinkai; K Eguchi; Y Sasaki; T Tamura; K Miura; Y Fujiwara; A Otsu; N Horiuchi; H Nakano
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  J Natl Cancer Inst       Date:  2015-02-09       Impact factor: 13.506

3.  A practical prognostic index for inoperable non-small-cell lung cancer.

Authors:  T Wigren; H Oksanen; P Kellokumpu-Lehtinen
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 4.  A systematic review of the impact of pain on overall survival in patients with cancer.

Authors:  Dylan Zylla; Grant Steele; Pankaj Gupta
Journal:  Support Care Cancer       Date:  2017-02-11       Impact factor: 3.603

Review 5.  The pathophysiology and management of spine metastasis from lung cancer.

Authors:  J S Greenberger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Influence of body mass index on survival in veterans with multiple myeloma.

Authors:  Tracey S Beason; Su-Hsin Chang; Kristen M Sanfilippo; Suhong Luo; Graham A Colditz; Ravi Vij; Michael H Tomasson; John F Dipersio; Keith Stockerl-Goldstein; Arun Ganti; Tanya Wildes; Kenneth R Carson
Journal:  Oncologist       Date:  2013-09-18

7.  Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.

Authors:  Jingbo Wang; Zongmei Zhou; Jun Liang; Qinfu Feng; Zefen Xiao; Zhouguang Hui; Xiaozhen Wang; Jima Lv; Dongfu Chen; Hongxing Zhang; Zhe Ji; Jianzhong Cao; Lipin Liu; Wei Jiang; Yu Men; Cai Xu; Jiangrong Dai; Weibo Yin; Luhua Wang
Journal:  Oncologist       Date:  2016-09-14

8.  Prediagnosis soy food consumption and lung cancer survival in women.

Authors:  Gong Yang; Xiao-Ou Shu; Hong-Lan Li; Wong-Ho Chow; Wanqing Wen; Yong-Bing Xiang; Xianglan Zhang; Hui Cai; Bu-Tian Ji; Yu-Tang Gao; Wei Zheng
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

9.  A randomized comparison of dilatation alone versus dilatation plus laser in patients receiving chemotherapy and external beam radiation for esophageal carcinoma.

Authors:  B S Anand; Z A Saeed; P A Michaletz; C B Winchester; M A Doherty; J H Liem; D Y Graham
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

Review 10.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.